cyproheptadine has been researched along with baclofen in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Nance, PW | 1 |
Barbeau, H; Norman, KE; Pépin, A | 1 |
Brunner, RC; Meythaler, JM; Roper, JF | 1 |
Elovic, E; Lombard, L; Zafonte, R | 1 |
Saveika, JA; Shelton, JE | 1 |
Hardman, MI; Sprung, J; Weingarten, TN | 1 |
3 review(s) available for cyproheptadine and baclofen
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antispasticity medications: uses and limitations of enteral therapy.
Topics: 4-Aminopyridine; Acetates; Adrenergic alpha-Agonists; Amines; Baclofen; Benzodiazepines; Cyclohexanecarboxylic Acids; Cyproheptadine; Dantrolene; Dronabinol; Gabapentin; gamma-Aminobutyric Acid; Glycine; Humans; Muscle Relaxants, Central; Muscle Spasticity; Neuroprotective Agents; Piracetam; Serotonin Antagonists | 2004 |
Acute phenibut withdrawal: A comprehensive literature review and illustrative case report.
Topics: Akathisia, Drug-Induced; Baclofen; Cyproheptadine; Dexmedetomidine; Diphenhydramine; GABA-A Receptor Antagonists; GABA-B Receptor Agonists; gamma-Aminobutyric Acid; Haloperidol; Humans; Lorazepam; Male; Melatonin; Neuroleptic Malignant Syndrome; Olanzapine; Receptors, GABA; Substance Withdrawal Syndrome; Substance-Related Disorders; Young Adult | 2019 |
2 trial(s) available for cyproheptadine and baclofen
Article | Year |
---|---|
A comparison of clonidine, cyproheptadine and baclofen in spastic spinal cord injured patients.
Topics: Baclofen; Clonidine; Cyproheptadine; Dose-Response Relationship, Drug; Drug Administration Schedule; H-Reflex; Humans; Muscle Spasticity; Muscle Tonus; Muscle, Skeletal; Neural Inhibition; Neurologic Examination; Range of Motion, Articular; Spinal Cord Injuries; Vibration | 1994 |
Effects of drugs on walking after spinal cord injury.
Topics: Adrenergic alpha-Agonists; Adult; Baclofen; Clonidine; Cyproheptadine; Electromyography; Exercise Test; GABA Agonists; Humans; Serotonin Antagonists; Spinal Cord Injuries; Walking | 1998 |
4 other study(ies) available for cyproheptadine and baclofen
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Cyproheptadine for intrathecal baclofen withdrawal.
Topics: Acute Disease; Adult; Baclofen; Cerebral Palsy; Cyproheptadine; Diagnosis, Differential; Female; Fever; Humans; Infusion Pumps, Implantable; Injections, Spinal; Male; Middle Aged; Muscle Hypertonia; Muscle Relaxants, Central; Muscle Spasticity; Serotonin Antagonists; Severity of Illness Index; Spinal Cord Injuries; Substance Withdrawal Syndrome; Tachycardia; Treatment Outcome | 2003 |
Cyproheptadine for pediatric intrathecal baclofen withdrawal: a case report.
Topics: Adolescent; Age Factors; Baclofen; Cerebral Palsy; Child; Cyproheptadine; Equipment Failure; Female; GABA Agonists; Histamine H1 Antagonists; Humans; Infusion Pumps; Injections, Spinal; Pruritus; Quadriplegia; Substance Withdrawal Syndrome | 2007 |